BIIB: Biogen Inc

BIIB haberleri

• Seeking Alpha 21:08 Alkermes: A More Than Solid Quarter (NASDAQ:ALKS)
• Investing 18:00 Apple, Amazon, Kla-tencor set to report earnings Thursday
• Investing 15:23 Lecanemab real-world study shows promising results in early Alzheimer’s
• Zacks 13:15 Biogen (BIIB) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
• Investing 19:43 Biotech stocks dip as Trump administration mulls patent fee overhaul
• Zacks 14:24 Biogen Gears Up to Report Q2 Earnings: Here's What to Expect
• Zacks 14:00 BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth
• Zacks 14:00 Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for
• TipRanks 10:46 QQQ ETF News, 7/24/2025 - TipRanks.com
• Benzinga 18:15 Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US - AstraZeneca (NASDAQ:AZN)
• Benzinga 17:05 FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division - Sarepta Therapeutics (NASDAQ:SRPT), Biogen (NASDAQ:BIIB)
• Investing 15:01 BMO Capital reiterates Eli Lilly stock rating with $900 price target
• Zacks 13:31 How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings?
• TipRanks 10:35 QQQ ETF News, 7/22/2025 - TipRanks.com
• Benzinga 18:25 Biogen Bets Big On $2 Billion Expansion To Boost US Drug Manufacturing - Biogen (NASDAQ:BIIB)
• Seeking Alpha 14:00 Eli Lilly: Competition Melts Away (NYSE:LLY)
• Investing 12:22 Truist Securities initiates Biogen stock coverage with Hold rating
• Investing 11:41 Biogen to invest $2 billion more in North Carolina
• Investing 11:36 Biogen to invest $2 billion in North Carolina manufacturing expansion
• Investing 13:14 Harrow Health stock outlook strong as Cantor reiterates Overweight rating
• Investing 00:58 Ionis Pharma CEO Monia sells $48,416 in stock
• Benzinga 17:52 Is Bristol-Myers Squibb Still An Undervalued Biopharma Play? - Bristol-Myers Squibb (NYSE:BMY)
• Investing 14:43 Biogen stock price target raised to $130 from $119 at UBS on Alzheimer’s outlook
• Seeking Alpha 19:34 Patient Capital Management Q2 2025 Investment Review